416 related articles for article (PubMed ID: 28350986)
1. Flow-Dependent Endothelial YAP Regulation Contributes to Vessel Maintenance.
Nakajima H; Yamamoto K; Agarwala S; Terai K; Fukui H; Fukuhara S; Ando K; Miyazaki T; Yokota Y; Schmelzer E; Belting HG; Affolter M; Lecaudey V; Mochizuki N
Dev Cell; 2017 Mar; 40(6):523-536.e6. PubMed ID: 28350986
[TBL] [Abstract][Full Text] [Related]
2. Atheroprotective laminar flow inhibits Hippo pathway effector YAP in endothelial cells.
Xu S; Koroleva M; Yin M; Jin ZG
Transl Res; 2016 Oct; 176():18-28.e2. PubMed ID: 27295628
[TBL] [Abstract][Full Text] [Related]
3. Micropatterning as a tool to identify regulatory triggers and kinetics of actin-mediated endothelial mechanosensing.
Gegenfurtner FA; Jahn B; Wagner H; Ziegenhain C; Enard W; Geistlinger L; Rädler JO; Vollmar AM; Zahler S
J Cell Sci; 2018 May; 131(10):. PubMed ID: 29724912
[TBL] [Abstract][Full Text] [Related]
4. Laminar flow inhibits the Hippo/YAP pathway via autophagy and SIRT1-mediated deacetylation against atherosclerosis.
Yuan P; Hu Q; He X; Long Y; Song X; Wu F; He Y; Zhou X
Cell Death Dis; 2020 Feb; 11(2):141. PubMed ID: 32081881
[TBL] [Abstract][Full Text] [Related]
5. Flow-dependent YAP/TAZ activities regulate endothelial phenotypes and atherosclerosis.
Wang KC; Yeh YT; Nguyen P; Limqueco E; Lopez J; Thorossian S; Guan KL; Li YJ; Chien S
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):11525-11530. PubMed ID: 27671657
[TBL] [Abstract][Full Text] [Related]
6. Yap/Taz transcriptional activity is essential for vascular regression via Ctgf expression and actin polymerization.
Nagasawa-Masuda A; Terai K
PLoS One; 2017; 12(4):e0174633. PubMed ID: 28369143
[TBL] [Abstract][Full Text] [Related]
7. Atheroprotective effects of methotrexate via the inhibition of YAP/TAZ under disturbed flow.
Liu D; Lv H; Liu Q; Sun Y; Hou S; Zhang L; Yang M; Han B; Wang G; Wang X; Du W; Nie H; Zhang R; Huang X; Hou J; Yu B
J Transl Med; 2019 Nov; 17(1):378. PubMed ID: 31730006
[TBL] [Abstract][Full Text] [Related]
8. Toxoplasma gondii Dysregulates Barrier Function and Mechanotransduction Signaling in Human Endothelial Cells.
Franklin-Murray AL; Mallya S; Jankeel A; Sureshchandra S; Messaoudi I; Lodoen MB
mSphere; 2020 Jan; 5(1):. PubMed ID: 31996420
[No Abstract] [Full Text] [Related]
9. Zebrafish mutants and TEAD reporters reveal essential functions for Yap and Taz in posterior cardinal vein development.
Astone M; Lai JKH; Dupont S; Stainier DYR; Argenton F; Vettori A
Sci Rep; 2018 Jul; 8(1):10189. PubMed ID: 29976931
[TBL] [Abstract][Full Text] [Related]
10. YAP/TAZ Orchestrate VEGF Signaling during Developmental Angiogenesis.
Wang X; Freire Valls A; Schermann G; Shen Y; Moya IM; Castro L; Urban S; Solecki GM; Winkler F; Riedemann L; Jain RK; Mazzone M; Schmidt T; Fischer T; Halder G; Ruiz de Almodóvar C
Dev Cell; 2017 Sep; 42(5):462-478.e7. PubMed ID: 28867486
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Yes-Associated Protein by Laminar Flow.
Chitragari G; Shalaby SY; Sumpio BJ; Kurita J; Sumpio BE
Ann Vasc Surg; 2018 Oct; 52():183-191. PubMed ID: 29758328
[TBL] [Abstract][Full Text] [Related]
12. F-actin dynamics regulates mammalian organ growth and cell fate maintenance.
Pocaterra A; Santinon G; Romani P; Brian I; Dimitracopoulos A; Ghisleni A; Carnicer-Lombarte A; Forcato M; Braghetta P; Montagner M; Galuppini F; Aragona M; Pennelli G; Bicciato S; Gauthier N; Franze K; Dupont S
J Hepatol; 2019 Jul; 71(1):130-142. PubMed ID: 30878582
[TBL] [Abstract][Full Text] [Related]
13. Regulation of YAP Promotor Accessibility in Endothelial Mechanotransduction.
Mannion AJ; Zhao H; Zhang Y; von Wright Y; Bergman O; Roy J; Saharinen P; Holmgren L
Arterioscler Thromb Vasc Biol; 2024 Mar; 44(3):666-689. PubMed ID: 38299356
[TBL] [Abstract][Full Text] [Related]
14. TNF-α-Induced YAP/TAZ Activity Mediates Leukocyte-Endothelial Adhesion by Regulating VCAM1 Expression in Endothelial Cells.
Choi HJ; Kim NE; Kim BM; Seo M; Heo JH
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30388809
[TBL] [Abstract][Full Text] [Related]
15. Angiomotins link F-actin architecture to Hippo pathway signaling.
Mana-Capelli S; Paramasivam M; Dutta S; McCollum D
Mol Biol Cell; 2014 May; 25(10):1676-85. PubMed ID: 24648494
[TBL] [Abstract][Full Text] [Related]
16. Oxidized low-density lipoprotein promotes vascular endothelial cell dysfunction by stimulating miR-496 expression and inhibiting the Hippo pathway effector YAP.
Hu J; Liu T; Zhang Z; Xu Y; Zhu F
Cell Biol Int; 2019 May; 43(5):528-538. PubMed ID: 30811087
[TBL] [Abstract][Full Text] [Related]
17. c-Abl regulates YAPY357 phosphorylation to activate endothelial atherogenic responses to disturbed flow.
Li B; He J; Lv H; Liu Y; Lv X; Zhang C; Zhu Y; Ai D
J Clin Invest; 2019 Mar; 129(3):1167-1179. PubMed ID: 30629551
[TBL] [Abstract][Full Text] [Related]
18. YAP and TAZ Negatively Regulate Prox1 During Developmental and Pathologic Lymphangiogenesis.
Cho H; Kim J; Ahn JH; Hong YK; Mäkinen T; Lim DS; Koh GY
Circ Res; 2019 Jan; 124(2):225-242. PubMed ID: 30582452
[TBL] [Abstract][Full Text] [Related]
19. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.
Mana-Capelli S; McCollum D
J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805
[TBL] [Abstract][Full Text] [Related]
20. The Hippo Pathway Regulates Caveolae Expression and Mediates Flow Response via Caveolae.
Rausch V; Bostrom JR; Park J; Bravo IR; Feng Y; Hay DC; Link BA; Hansen CG
Curr Biol; 2019 Jan; 29(2):242-255.e6. PubMed ID: 30595521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
